IL6 and Alzheimer disease: SHCGT contains several compounds that are known to attenuate AD, including berberine and paeoniflorin (Tsang et al., 2016; Jo et al., 2018), and was also found to decrease the expression of IL-6 in an in vitro model of AD in our study.